# FDA Inspection 922107 - LifeSource dba Central Blood Bank - April 09, 2015

Source: https://www.keypedia.com/records/fda_inspections/lifesource-dba-central-blood-bank/024ae614-ae74-4057-81e4-e00af3010861
Source feed: FDA_Inspections

> FDA Inspection 922107 for LifeSource dba Central Blood Bank on April 09, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 922107
- Company Name: LifeSource dba Central Blood Bank
- Inspection Date: 2015-04-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1005615 - 2017-03-27](https://www.keypedia.com/records/fda_inspections/lifesource-dba-central-blood-bank/e3e21cd6-1a95-4a0d-9081-053139999907)
- [FDA Inspection 815716 - 2013-01-24](https://www.keypedia.com/records/fda_inspections/lifesource-dba-central-blood-bank/536971b8-aa75-435c-969a-0bc7693c33f8)
- [FDA Inspection 718569 - 2011-04-05](https://www.keypedia.com/records/fda_inspections/lifesource-dba-central-blood-bank/0f19c0e4-a3ed-43b2-b467-ea48439b09fd)
- [FDA Inspection 617145 - 2009-10-02](https://www.keypedia.com/records/fda_inspections/lifesource-dba-central-blood-bank/e11fa5ad-8efb-4466-9870-6dbd1bb66521)

Company: https://www.keypedia.com/companies/lifesource-dba-central-blood-bank/302e8956-0906-4e59-a866-c1c76a9673dd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d